✦ LIBER ✦

Non-homogeneous Markov models in the analysis of survival after breast cancer

✍ Scribed by Rafael Pérez-Ocón; Juan Eloy Ruiz-Castro; M. Luz Gámiz-Pérez

Book ID: 108547893
Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 257 KB
Volume: 50
Category: Article
ISSN: 0035-9254
DOI: 10.1111/1467-9876.00223

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

52 Oral Transition probabilities among s

52 Oral Transition probabilities among states and long-term survival in high risk breast cancer patients. A non homogeneous Markov's model analysis

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 154 KB

Analysis of surviving cells in breast ca

Analysis of surviving cells in breast cancer after photodynamic therapy

✍ Juliana Ferreira; Clovis Grecco; Isabelle Ferreira; Jose Dirceu Vollet-Filho; Al 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Clinical and multiple gene expression va

Clinical and multiple gene expression variables in survival analysis of breast cancer: Analysis with the hypertabastic survival model

✍ Mohammad A Tabatabai, Wayne M Eby, Nadim Nimeh, Hong Li, Karan P Singh 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 555 KB

Markov models with lognormal transition

Markov models with lognormal transition rates in the analysis of survival times

✍ Rafael Pérez-Ocón; J. Eloy Ruiz-Castro; M. Luz Gámiz-Pérez 📂 Article 📅 2000 🏛 CrossRef test prefix 🌐 English ⚖ 728 KB

Transition (markov) models for the analy

Transition (markov) models for the analysis of survival times in clinical research

✍ Sati Mazumdar, ; Kenneth Liu, ; Sang Ahnn, ; Houck, Patricia R.; Reynolds, Charl 📂 Article 📅 1999 🏛 Taylor and Francis Group 🌐 English ⚖ 376 KB

Survival of breast cancer patients in BR

Survival of breast cancer patients in BRCA1, BRCA2, and non-BRCA1/2 breast cancer families: A relative survival analysis from Finland

✍ Hannaleena Eerola; Pia Vahteristo; Laura Sarantaus; Pentti Kyyrönen; Seppo Pyrhö 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 69 KB 👁 1 views

Reports on the prognosis of familial breast cancer patients have been contradictory. True differences in survival, if they exist, would have important implications for genetic counselling and in treatment of hereditary breast cancer. We assessed the survival rates of 359 familial breast cancer patie